Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07639255 · ClinicalTrials.gov registry record · NA
Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation
A NA study, sponsored by Timothy Mullett.
- Recruiting
- Registry status
- NA
- Development phase
- 330
- Enrollment target
NCT07639255 is a NA study that is actively recruiting participants, run by Timothy Mullett. The registered enrollment target is 330 participants.
The verdict
NCT07639255, a NA study, is actively recruiting participants, sponsored by Timothy Mullett.
- RECRUITING
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
Study Summary
This is an optimization pathway for lung cancer screening programs. Enrolled programs will undergo an audit for elements associated with improved quality and retention of patients in the screening process. A feedback report is delivered to identify priorities for process improvement.
Interventions
- OTHER QUILS System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2028-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07639255
The ClinicalTrials.gov registry entry for NCT07639255 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 330 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Timothy Mullett, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which QUILS System is the first listed.
NCT07639255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07639255 about?
NCT07639255 is a clinical study titled "Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation". This is an optimization pathway for lung cancer screening programs. Enrolled programs will undergo an audit for elements associated with improved quality and retention of patients in the screening process. A feedback report is delivered to identify priorities for process improvement.
What is the current status of trial NCT07639255?
This trial is currently recruiting. It is a NA study. The enrollment target is 330 participants. The study started on 2025-04-01. Estimated completion is 2028-06-01.
What interventions are being tested in trial NCT07639255?
The interventions under investigation include: QUILS System (OTHER).
Who is sponsoring clinical trial NCT07639255?
This trial is sponsored by Timothy Mullett, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.